No Cold Drug Combos for Kids Under 4
New Delhi, August 22, 2026The government has tightened medicine safety measures for young children by restricting the manufacture, sale and distribution of fixed-dose combinations (FDCs) containing Chlorpheniramine Maleate and Phenylephrine Hydrochloride for children below four years of age. The decision is aimed at protecting children from possible health risks associated with these drug combinations.Manufacturers have now been directed to prominently carry the warning, “Fixed Dose Combination shall not be used in children below four years of age,” on product labels, package inserts and promotional literature. The mandatory warning is intended to clearly communicate that these formulations should not be used for children under the age of four.The...
Nanded University Bags Patent for Advanced TB Drug Delivery System
New Delhi, August 20, 2026Swami Ramanand Teerth Marathwada University in Nanded has secured an Indian patent for a nanostructured drug delivery technology designed to address a key challenge in tuberculosis treatment—the poor water solubility of certain anti-tubercular medicines. The innovation represents a step towards improving modern drug delivery methods and enhancing the therapeutic potential of such drugs.The patent, titled “Nanostructured Delivery Device for Poorly Water-Soluble Anti-Tubercular Drugs and Method Thereof,” has been granted to the university for 20 years, according to an official release. The research centres on a nanostructured delivery system intended to improve how anti-tubercular medicines with low water solubility are delivered.According...
अपनी सांस की सेहत का रखें ख्याल, धूल-धुएं से बचाव के साथ अपनाएं ये आसान उपाय
दिन पर दिन देश में हवा में बढ़ता धुआं, धूल और पार्टिकुलेट प्रदूषण सिर्फ बाहर निकलने में परेशानी नहीं पैदा करता, बल्कि सांस से जुड़ी दिक्कतों को भी बढ़ा सकता है। खासकर बच्चों, बुजुर्गों और पहले से अस्थमा या किसी दूसरी सांस की बीमारी से जूझ रहे लोगों को प्रदूषित हवा में ज्यादा सावधानी बरतने की जरूरत होती है।...
India’s ‘Smart’ Cancer Drug RK-251 Targets Tumour Cells, Spares Healthy Tissue
New Delhi, August 19, 2026Indian scientists have developed a promising experimental cancer drug designed to work more selectively on tumour cells, potentially addressing one of the major limitations of conventional chemotherapy—the damage it can cause to healthy tissues. The candidate, RK-251, has been developed through collaborative research led by Dr. Asis Bala of the Institute of Advanced Study in Science and Technology (IASST) and Dr. K.P. Bhabak of the Indian Institute of Technology-Guwahati.Unlike traditional chemotherapy, which can affect both cancerous and healthy cells, RK-251 is designed to remain largely inactive in normal tissues and become activated under conditions commonly associated with cancer cells. Tumour cells often have elevated...
ESIC Expands Healthcare Network with Seven New Projects
New Delhi, July 12, 2026Strengthening healthcare access for insured workers remains a key priority as the Employees' State Insurance Corporation (ESIC) continues to expand its medical infrastructure across India. In a major step toward improving healthcare services, Union Minister for Labour and Employment Dr. Mansukh Mandaviya will inaugurate seven ESI healthcare projects from the ESIC Hospital in Sanathnagar, Telangana, on July 14, 2026.During the event, Dr. Mandaviya will formally inaugurate the hospital's newly constructed OPD block at Sanathnagar and virtually launch six additional projects. These include the upgraded 200-bed ESIC Hospital at Beltola in Assam, a 100-bed ESIC Hospital at Sriperumbudur in Tamil Nadu, an ESIC Hospital at Rajamahendravaram...
Ebola Outbreak Spreads Further in DR Congo
New Delhi, July 9, 2026The Ebola outbreak in the Democratic Republic of Congo continues to widen, with suspected cases emerging in a new province, highlighting the growing challenge for health authorities. As the virus reaches additional areas, officials are strengthening surveillance and containment efforts to prevent further transmission.According to the latest government situation report, the outbreak, declared on May 15, has officially infected 1,759 people across the eastern provinces of Ituri, North Kivu, and South Kivu, while the death toll has reached 600. The report also noted two suspected cases in Kisangani, the capital of Tshopo province. One case has been linked to the Niania health zone in Ituri, where the outbreak first began, while the...
Sign up for the Newsletter
Join our newsletter and get updates in your inbox. We won’t spam you and we respect your privacy.